Displaying 13 - 24 of 87
Metabolism, Alcohol & Toxicity

Novo Nordisk: Updates on the essence of MASH (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Boehringer Ingelheim: A patient journey in MASH: Advancing care through collaborative innovation (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD's impact on metabolic health and quality of life – new evidence (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Integrating MASLD/MASH-Specific Therapy into Guideline-Aligned Real-World Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the MASH Paradigm With THR-β Agonists and Other Disease-Specific Therapies

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration (Comp...

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence (Complete Sess...

Webcasts
View
Metabolism, Alcohol & Toxicity

MASLD – current treatment  strategies  - from metabolic indices to patient reported outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Focusing on metabolic risk of MASLD. EXCEL study design and major outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Displaying 13 - 24 of 87